The dual role of CXCL8 in human CNS stem cell function: Multipotent neural stem cell death and oligodendrocyte progenitor cell chemotaxis

GLIA

Volumn 59, Issue 12, 2011, Pages 1864-1878

  Kelland, Eve E ^a   Gilmore, Wendy ^a   Weiner, Leslie P ^a   Lund, Brett T ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Chemokines; CXCR1; CXCR2; Migration; Stem cell biology

Indexed keywords

A2B5 PROTEIN; ALKALINE PHOSPHATASE; CASPASE 3; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NERVE PROTEIN; NESTIN; NG2 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN BCL 2; PROTEOLIPID PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL LINE; MYELINATION; NEURAL STEM CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL DEATH; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS, LEUKOCYTE; HUMANS; INTERLEUKIN-8; MULTIPLE SCLEROSIS; MULTIPOTENT STEM CELLS; NERVE FIBERS, MYELINATED; NEURAL STEM CELLS; OLIGODENDROGLIA; PRIMARY CELL CULTURE;

EID: 80053567604     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21230     Document Type: Article

References (92)

1. Akhtar RS, Geng Y, Klocke BJ, Roth KA. 2006. Neural precursor cells possess multiple p53-dependent apoptotic pathways. Cell Death Differ 13: 1727-1739.
2. Ambrosini E, Aloisi F. 2004. Chemokines and glial cells: A complex network in the central nervous system. Neurochem Res 29: 1017-1038.
3. Bachmann R, Eugster HP, Frei K, Fontana A, Lassmann H. 1999. Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. Am J Pathol 154: 1417-1422.
4. Baggiolini M, Loetscher P, Moser B. 1995. Interleukin-8 and the chemokine family. Int J Immunopharmacol 17: 103-108.
5. Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G. 2001. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 22: 147-184.
6. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 55: 458-468.
7. Bartosik-Psujek H, Stelmasiak Z. 2005. The levels of chemokines CXCL8, CCL2 and CCL5 in multiple sclerosis patients are linked to the activity of the disease Eur J Neurol 12: 49-54.
8. Beech JS, Wheeler DW, Reckless J, Grant AJ, Price J, Mastroeni P, Grainger DJ, Menon DK. 2007. The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro. J Neuroimmunol 184: 198-208.
9. Belmadani A, Tran PB, Ren D, Miller RJ. 2006. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J Neurosci 26: 3182-3191.
10. Bird TD, Farrell DF, Sumi SM. 1978. Brain lipid composition of the shiverer mouse: Genetic defect in myelin development. J Neurochem 31: 387-391.
11. Browning DD, Diehl WC, Hsu MH, Schraufstatter IU, Ye RD. 2000. Autocrine regulation of interleukin-8 production in human monocytes. Am J Physiol Lung Cell Mol Physiol 279: L1129-L1136.
12. Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID, McKay RD. 1999. Embryonic stem cell-derived glial precursors: A source of myelinating transplants. Science 285: 754-756.
13. Carbajal KS, Schaumburg C, Strieter R, Kane J, Lane TE. 2010. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc Natl Acad Sci USA 107: 11068-11073.
14. Cartier L, Hartley O, Dubois-Dauphin M, Krause KH. 2005. Chemokine receptors in the central nervous system: Role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev 48: 16-42.
15. Catalano M, Trettel F, Cipriani R, Lauro C, Sobrero F, Eusebi F, Limatola C. 2008. Chemokine CXCL8 modulates GluR1 phosphorylation. J Neuroimmunol 198: 75-81.
16. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. 2000. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20: 6404-6412.
17. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C. 2002. Re-expression of PSA-NCAM by demyelinated axons: An inhibitor of remyelination in multiple sclerosis? Brain 125: 1972-1979.
18. Charo IF, Ransohoff RM. 2006. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621.
19. Choi WT, Kaul M, Kumar S, Wang J, Kumar IM, Dong CZ, An J, Lipton SA, Huang Z. 2007. Neuronal apoptotic signaling pathways probed and intervened by synthetically and modularly modified (SMM) chemokines. J Biol Chem 282: 7154-7163.
20. Cimini A, Bernardo A, Cifone MG, Di Marzio L, Di Loreto S. 2003. TNFalpha downregulates PPARdelta expression in oligodendrocyte progenitor cells: Implications for demyelinating diseases. Glia 41: 3-14.
21. de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP. 2007. Neuronal chemokines: Versatile messengers in central nervous system cell interaction. Mol Neurobiol 36: 137-151.
22. Deverman BE, Patterson PH. 2009. Cytokines and CNS development. Neuron 64: 61-78.
23. DiMango E, Zar HJ, Bryan R, Prince A. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. JClin Invest 96: 2204-2210.
24. Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M. 2005. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 50: 258-269.
25. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH. 2009. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23: 1571-1585.
26. Feldhaus B, Dietzel ID, Heumann R, Berger R. 2004. Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors. JSoc Gynecol Investig 11: 89-96.
27. Filbin MT. 2003. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 4: 703-713.
28. Filipovic R, Jakovcevski I, Zecevic N. 2003. GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev Neurosci 25: 279-290.
29. Filipovic R, Zecevic N. 2008. The effect of CXCL1 on human fetal oligodendrocyte progenitor cells. Glia 56: 1-15.
30. Folkesson HG, Matthay MA, Hebert CA, Broaddus VC. 1995. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 96: 107-116.
31. Foote AK, Blakemore WF. 2005. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 128: 528-539.
32. Frohman EM, Racke MK, Raine CS. 2006. Multiple sclerosis-The plaque and its pathogenesis. N Engl J Med 354: 942-955.
33. Galimberti D, Bresolin N, Scarpini E. 2004. Chemokine network in multiple sclerosis: Role in pathogenesis and targeting for future treatments. Expert Rev Neurother 4: 439-453.
34. Geeraerts T, Deiva K, M'Sika I, Salim H, Hery C, Tardieu M. 2006. Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. Neurosci Lett 399: 115-120.
35. Goldberg JL, Barres BA. 2000. Nogo in nerve regeneration. Nature 403: 369-470.
36. Gordon RJ, McGregor AL, Connor B. 2009. Chemokines direct neural progenitor cell migration following striatal cell loss. Mol Cell Neurosci 41: 219-232.
37. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, Horuk R. 1998. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 8: 595-598.
38. Huang D, Han Y, Rani MR, Glabinski A, Trebst C, Sorensen T, Tani M, Wang J, Chien P, O'Bryan S, Bielecki B, Zhou ZL, Majumder S, Ransohoff RM. 2000. Chemokines and chemokine receptors in inflammation of the nervous system: Manifold roles and exquisite regulation. Immunol Rev 177: 52-67.
39. Izrael M, Zhang P, Kaufman R, Shinder V, Ella R, Amit M, Itskovitz-Eldor J, Chebath J, Revel M. 2007. Human oligodendrocytes derived from embryonic stem cells: Effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 34: 310-323.
40. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF. 2002. Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8: 1115-1121.
41. Jones KH, Sneft JA. 1985. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J Histochem Cytochem 33: 77-79.
42. Kadi L, Selvaraju R, de Lys P, Proudfoot AE, Wells TN, Boschert U. 2006. Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J Neuroimmunol 174: 133-146.
43. Keegan BM, Noseworthy JH. 2002. Multiple sclerosis. Annu Rev Med 53: 285-302.
44. Kelland EE, Toms NJ. 2001. Group I metabotropic glutamate receptors limit AMPA receptor-mediated oligodendrocyte progenitor cell death. Eur J Pharmacol 424: R3-R4.
45. Kim MS, Day CJ, Morrison NA. 2005. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem 280: 16163-16169.
46. Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ, Hughes BJ, Youker KA, Hawkins HK, Michael LH. 1995. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 95: 89-103.
47. Lassmann H. 1999. The pathology of multiple sclerosis and its evolution. Philos Trans R Soc Lond B Biol Sci 354: 1635-1640.
48. Lund BT, Ashikian N, Ta HQ, Chakryan Y, Manoukian K, Groshen S, Gilmore W, Cheema GS, Stohl W, Burnett ME, Ko D, Kachuck NJ, Weiner LP. 2004. Increased CXCL8 (IL-8) expression in multiple sclerosis. J Neuroimmunol 155: 161-171.
49. Lund BT, Kelland EE. 2008. Measuring apoptosis in neural stem cells. Methods Mol Biol 438: 227-241.
50. Maheshwari A, Lacson A, Lu W, Fox SE, Barleycorn AA, Christensen RD, Calhoun DA. 2004. Interleukin-8/CXCL8 forms an autocrine loop in fetal intestinal mucosa. Pediatr Res 56: 240-249.
51. Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samartin A, Sanchez-Gomez MV. 2001. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 24: 224-230.
52. McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW. 1999. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 5: 1410-1412.
53. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. 2005. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 8: 745-751.
54. Molineaux SM, Engh H, de Ferra F, Hudson L, Lazzarini RA. 1986. Recombination within the myelin basic protein gene created the dysmyelinating shiverer mouse mutation. Proc Natl Acad Sci USA 83: 7542-7546.
55. Monje ML, Toda H, Palmer TD. 2003. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302: 1760-1765.
56. Mukaida N, Harada A, Matsushima K. 1995. A novel leukocyte chemotactic and activating cytokine, interleukin-8 (IL-8). Cancer Treat Res 80: 261-286.
57. Mukaida N, Harada A, Yasumoto K, Matsushima K. 1992. Properties of pro-inflammatory cell type-specific leukocyte chemotactic cytokines, interleukin 8 (IL-8) and monocyte chemotactic and activating factor (MCAF). Microbiol Immunol 36: 773-789.
58. Navikas V, Link H. 1996. Review: Cytokines and the pathogenesis of multiple sclerosis. JNeurosci Res 45: 322-333.
59. Nguyen D, Stangel M. 2001. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Brain Res Dev Brain Res 128: 77-81.
60. Ni HT, Hu S, Sheng WS, Olson JM, Cheeran MC, Chan AS, Lokensgard JR, Peterson PK. 2004. High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res 152: 159-169.
61. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. 2005. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49: 385-396.
62. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. 2000. Multiple sclerosis. N Engl J Med 343: 938-952.
63. Omari KM, John G, Lango R, Raine CS. 2006. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53: 24-31.
64. Omari KM, John GR, Sealfon SC, Raine CS. 2005. CXC chemokine receptors on human oligodendrocytes: Implications for multiple sclerosis. Brain 128: 1003-1015.
65. Omari KM, Lutz SE, Santambrogio L, Lira SA, Raine CS. 2009. Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am J Pathol 174: 164-176.
66. Pitt D, Nagelmeier IE, Wilson HC, Raine CS. 2003. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 61: 1113-1120.
67. Pitt D, Werner P, Raine CS. 2000. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6: 67-70.
68. Prat A, Biernacki K, Lavoie JF, Poirier J, Duquette P, Antel JP. 2002. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch Neurol 59: 391-397.
69. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. 1993. Multiple sclerosis: Remyelination of nascent lesions. Ann Neurol 33: 137-151.
70. Ramjeesingh R, Leung R, Siu CH. 2003. Interleukin-8 secreted by endothelial cells induces chemotaxis of melanoma cells through the chemokine receptor CXCR1. FASEB J 17: 1292-1294.
71. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. 1998. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18: 10457-1063.
72. Rosenbluth J. 1980. Central myelin in the mouse mutant shiverer. J Comp Neurol 194: 639-648.
73. Simpson J, Rezaie P, Newcombe J, Cuzner ML, Male D, Woodroofe MN. 2000a. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue J Neuroimmunol 108: 192-200.
74. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. 1998. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 84: 238-249.
75. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. 2000b. Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 26: 133-142.
76. Snethen H, Love S, Scolding N. 2008. Disease-responsive neural precursor cells are present in multiple sclerosis lesions. Regen Med 3: 835-847.
77. Subileau EA, Rezaie P, Davies HA, Colyer FM, Greenwood J, Male DK, Romero IA. 2009. Expression of chemokines and their receptors by human brain endothelium: Implications for multiple sclerosis. JNeuropathol Exp Neurol 68: 227-240.
78. Szczucinski A, Losy J. 2007. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol Scand 115: 137-146.
79. Tran PB, Banisadr G, Ren D, Chenn A, Miller RJ. 2007. Chemokine receptor expression by neural progenitor cells in neurogenic regions of mouse brain. JComp Neurol 500: 1007-1033.
80. Tran PB, Ren D, Veldhouse TJ, Miller RJ. 2004. Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J Neurosci Res 76: 20-34.
81. Tsai HH, Frost E, To V, Robinson S, Ffrench-Constant C, Geertman R, Ransohoff RM, Miller RH. 2002. The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110: 373-383.
82. van der Meulen AA, Biber K, Lukovac S, Balasubramaniyan V, den Dunnen WF, Boddeke HW, Mooij JJ. 2009. The role of CXC chemokine ligand (CXCL)12-CXC chemokine receptor (CXCR)4 signalling in the migration of neural stem cells towards a brain tumour. Neuropathol Appl Neurobiol 35: 579-591.
83. Vartanian T, Li Y, Zhao M, Stefansson K. 1995. Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol Med 1: 732-743.
84. Wachs FP, Winner B, Couillard-Despres S, Schiller T, Aigner R, Winkler J, Bogdahn U, Aigner L. 2006. Transforming growth factor-beta1 is a negative modulator of adult neurogenesis. J Neuropathol Exp Neurol 65: 358-370.
85. Walz A, Peveri P, Aschauer H, Baggiolini M. 1987. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 149: 755-761.
86. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA. 1998. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21: 63-75.
87. Wang Z, Colognato H, Ffrench-Constant C. 2007. Contrasting effects of mitogenic growth factors on myelination in neuron-oligodendrocyte co-cultures. Glia 55: 537-545.
88. Wolswijk G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. JNeurosci 18: 601-609.
89. Wolswijk G. 2000. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123): 105-115.
90. Wolswijk G. 2002. Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125: 338-349.
91. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84: 9233-9237.
92. Zhang SC, Wernig M, Duncan ID, Brustle O, Thomson JA. 2001. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19: 1129-1133.